Abbott (ABT) Announces $5B Buyback
More News related to ABT
- Abbott Labs (ABT) Reaches Settlements in Litigation Related to Direct Purchaser Class Action; to Pay $184M
- Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: NVS, JNJ, PFE, GSK, ABT, AZN
- Holiday travelers beware: Every 50 seconds a laptop goes missing at U.S. airports(1)
- Short Seller Chanos Eyes Medical Sector
- Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers
More News related to Stock Buybacks
- The Hartford (HIG) Talks About Its Highly Rated CMBS Portfolio
- PepsiCo (PEP) to Invest $3 Billion in Mexico Operations
- Quicksilver Resources (KWK) Announces '09 Capital Budget
- Cosi, Inc. (COSI) Forms Special Committee to Review Strategic Alternatives
- Par Pharmaceutical (PRX) Halts Shipments of of Budesonide Inhalation Suspension
Abbott (NYSE: ABT) said its board of directors has authorized the repurchase of up to $5 billion of the corporation's common stock.
Abbott said the purchases may be made from time to time as market conditions warrant and subject to regulatory considerations. The timing and amounts of any purchases will be determined by the company's management. The share repurchase authorization has no time limit and may be discontinued at any time.
Related Categories
Stock BuybacksStocks Mentioned
-4.17Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
